Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study
April 18, 2019 at 18:14 PM EDT
A lower dose of non-opioid painkiller developed by Pfizer Inc and Eli Lilly and Co failed to meet main goals in a late-stage study in patients with moderate-to-severe osteoarthritis of the hip or knee, the companies said on Thursday.